Diabetes Home > Invokana and Breastfeeding
Although Invokana (canagliflozin) does pass through breast milk in rats, it is unknown if it passes through breast milk in women. The manufacturer of the drug recommends that women who are breastfeeding should not take Invokana. If you are thinking about taking this medication while nursing, talk to your healthcare provider. Together, you can make the best choice for you and your child.
At this time, it is unknown if Invokana® (canagliflozin) is safe for use in nursing women. The manufacturer of Invokana states that this medication should not be used in women who are nursing. If you are currently breastfeeding or plan to start, talk to your healthcare provider before taking this medication.
Although Invokana is known to pass through breast milk in rats, it is unknown if the same is true for humans. In studies, baby rats that were exposed to Invokana developed kidney maturation problems. Because of this risk, the manufacturer of Invokana does not recommend its use during breastfeeding. Other options include insulin or some of the older oral diabetes medications that are safer during breastfeeding, or formula feeding.
You should discuss breastfeeding and Invokana use with your healthcare provider. Each woman's situation is different, and you and your healthcare provider understand your situation best. After considering what you want and expect, as well as your current health situation, the two of you can make a shared decision that is right for you.